• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后激素替代疗法对乳房X线密度和实质模式的影响。

Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.

作者信息

Laya M B, Gallagher J C, Schreiman J S, Larson E B, Watson P, Weinstein L

机构信息

Department of Medicine, University of Washington, Seattle 98195, USA.

出版信息

Radiology. 1995 Aug;196(2):433-7. doi: 10.1148/radiology.196.2.7617857.

DOI:10.1148/radiology.196.2.7617857
PMID:7617857
Abstract

PURPOSE

To measure changes and predictors of change in mammograms obtained in postmenopausal women undergoing continuous combined hormonal replacement therapy (HRT).

MATERIALS AND METHODS

Mammograms of 41 postmenopausal women obtained before and 1 year after the initiation of HRT were evaluated blindly according to the quantitative density percentage method and the Wolfe classification system.

RESULTS

Mammographic densities increased compared with baseline values in 73% of subjects (mean increase, 6.7%; 95% confidence interval, 2.5%, 11.0%; P = .003). A shift in Wolfe classification from lower to greater parenchymal density was noted in 24% of subjects (P = .016). Multivariate analysis results indicated that the lower the tissue density percentage before treatment, the greater the increase in density percentage after treatment.

CONCLUSION

An increase in mammographic density was demonstrated in most subjects undergoing continuous combined HRT and was most pronounced in subjects with a lower baseline density percentage.

摘要

目的

测量接受连续联合激素替代疗法(HRT)的绝经后女性乳房X线照片的变化及变化的预测因素。

材料与方法

根据定量密度百分比法和沃尔夫分类系统,对41名绝经后女性在开始HRT前和开始后1年获得的乳房X线照片进行盲法评估。

结果

73%的受试者乳房X线密度较基线值增加(平均增加6.7%;95%置信区间,2.5%,11.0%;P = .003)。24%的受试者沃尔夫分类从较低的实质密度转变为较高的实质密度(P = .016)。多变量分析结果表明,治疗前组织密度百分比越低,治疗后密度百分比增加越大。

结论

大多数接受连续联合HRT的受试者乳房X线密度增加,且在基线密度百分比较低的受试者中最为明显。

相似文献

1
Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.绝经后激素替代疗法对乳房X线密度和实质模式的影响。
Radiology. 1995 Aug;196(2):433-7. doi: 10.1148/radiology.196.2.7617857.
2
Postmenopausal hormone therapy and mammographic breast density.绝经后激素治疗与乳腺钼靶密度
Maturitas. 2006 Jan 10;53(1):59-64. doi: 10.1016/j.maturitas.2005.02.010. Epub 2005 Jun 6.
3
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.绝经后女性中雌激素加孕激素的使用与乳腺X线密度:妇女健康倡议随机试验
J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76. doi: 10.1093/jnci/dji279.
4
Postmenopausal hormone therapy and change in mammographic density.绝经后激素治疗与乳房X线密度变化
J Natl Cancer Inst. 2003 Jan 1;95(1):30-7. doi: 10.1093/jnci/95.1.30.
5
Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.激素替代疗法期间的乳腺钼靶密度:连续联合、非对抗性经皮和低效雌激素方案的影响。
Climacteric. 2001 Mar;4(1):42-8.
6
Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.雌激素和雌激素 - 孕激素对乳腺X线实质密度的影响。绝经后雌激素/孕激素干预(PEPI)研究组。
Ann Intern Med. 1999 Feb 16;130(4 Pt 1):262-9. doi: 10.7326/0003-4819-130-4_part_1-199902160-00003.
7
Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.戊酸雌二醇与地诺孕素或醋酸炔诺酮长期连续联合激素替代疗法对绝经后女性乳腺X线密度的影响。
Medscape Womens Health. 2002 Jul-Aug;7(4):1.
8
Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.在绝经后雌激素/孕激素干预(PEPI)试验中,接受雌激素和孕激素联合治疗的女性,血清雌酮的治疗后变化可预测乳房X线密度百分比的变化。
J Clin Oncol. 2004 Jul 15;22(14):2842-8. doi: 10.1200/JCO.2004.03.120.
9
Mammographic density increase in women receiving different hormone replacement regimens.接受不同激素替代方案的女性乳房X线密度增加。
Maturitas. 2001 Nov 30;40(2):151-7. doi: 10.1016/s0378-5122(01)00236-5.
10
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.雌激素和孕激素治疗引起的乳房X线密度变化与乳腺癌风险
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx001.

引用本文的文献

1
Digital Mammography (DM) vs. Dynamic Contrast Enhancement-Magnetic Resonance Imaging (DCE-MRI) in Microcalcifications Assessment: A Radiological-Pathological Comparison.数字乳腺摄影(DM)与动态对比增强磁共振成像(DCE-MRI)在微钙化评估中的应用:放射学与病理学比较
Diagnostics (Basel). 2024 May 21;14(11):1063. doi: 10.3390/diagnostics14111063.
2
The Relationship Between Mammographic Density and Factors Affecting Breast Cancer Risk.乳腺钼靶密度与影响乳腺癌风险因素之间的关系
Sisli Etfal Hastan Tip Bul. 2022 Mar 28;56(1):119-125. doi: 10.14744/SEMB.2021.30771. eCollection 2022.
3
Mammographic density: intersection of advocacy, science, and clinical practice.
乳腺钼靶密度:倡导、科学与临床实践的交叉点。
Curr Breast Cancer Rep. 2019 Sep;11(3):100-110. doi: 10.1007/s12609-019-00316-4. Epub 2019 Jul 24.
4
Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.绝经前雌激素受体阳性乳腺癌妇女停用他莫昔芬后乳腺密度的变化。
Eur Radiol. 2018 Aug;28(8):3176-3184. doi: 10.1007/s00330-017-5293-y. Epub 2018 Apr 6.
5
MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women.MRI 脑实质增强、绝经后妇女的乳房密度和血清激素。
Int J Cancer. 2018 Aug 15;143(4):823-830. doi: 10.1002/ijc.31370. Epub 2018 Mar 25.
6
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.雌激素和孕激素治疗引起的乳房X线密度变化与乳腺癌风险
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx001.
7
No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density.未发现有丝分裂相关基因遗传变异与乳腺 X 线密度百分比之间存在关联。
Breast Cancer Res. 2012 Jan 7;14(1):R7. doi: 10.1186/bcr3088.
8
Reproductive and menstrual factors and mammographic density in African American, Caribbean, and white women.非裔美国、加勒比和白人女性的生殖和月经因素与乳腺 X 光密度。
Cancer Causes Control. 2011 Apr;22(4):599-610. doi: 10.1007/s10552-011-9733-8. Epub 2011 Feb 17.
9
Breast density in women with premature ovarian failure or postmenopausal women using hormone therapy: analytical cross-sectional study.卵巢早衰女性或使用激素疗法的绝经后女性的乳腺密度:分析性横断面研究。
Sao Paulo Med J. 2010 Jul;128(4):211-4. doi: 10.1590/s1516-31802010000400007.
10
Short-term hormone therapy suspension and mammography recall: a randomized trial.短期激素治疗中断与乳房X光检查召回:一项随机试验。
Ann Intern Med. 2009 Jun 2;150(11):752-65. doi: 10.7326/0003-4819-150-11-200906020-00003.